Myocarditis - clinical course and 2-year outcome in 32 patients.

BACKGROUND Acute myocarditis is one of the most challenging diagnoses in cardiology. It is a disease with variable clinical presentation, progression and outcome. AIM To assess clinical characteristics and outcome of patients hospitalised with diagnosis of acute myocarditis from year 2006 to 2008. METHODS We analysed hospital files of consecutive 32 patients admitted to our hospital due to myocarditis. All demographic, clinical and laboratory data were analysed and compared between patients with acute or subacute myocarditis. After discharge the patients were followed for 8-24 months. RESULTS The majority of patients were males (84%) in a mean age of 33 years. Clinical and echocardiographic parameters improved in 25 (78%) of patients during hospital stay. During follow-up decreased left ventricular ejection fraction (LVEF) was observed more often in patients with subacute than acute myocarditis (mean LVEF values of 49 vs. 61%, respectively). Patients with a subacute form of the disease more frequently required chronic pharmacological therapy and more often retired from occupational activities. CONCLUSIONS Diagnosis of myocarditis is still challenging. Careful history taking, serial laboratory, ECG and echocardiographic examinations are helpful in therapeutic decisions making and assessing prognosis. Patient with subacute myocarditis are more symptomatic than patients with acute myocarditis.

[1]  P. Lipiec Zapalenie mięśnia sercowego - wyzwanie dla współczesnej kardiologii , 2009 .

[2]  S. Heymans,et al.  Acute viral myocarditis , 2008, European heart journal.

[3]  M. Imazio,et al.  Myopericarditis: Etiology, management, and prognosis. , 2008, International journal of cardiology.

[4]  K. Kawecka-Jaszcz,et al.  Myopericarditis przebiegające ze wstrząsem kardiogennym i obrazem klinicznym zawału ściany dolnej u mężczyzny z nadczynnością tarczycy i cukrzycą Myopericarditis complicated with cardiogenic shock mimicking acute coronary syndrome with ST elevation in a patient with hyperthyroidism and diabetes mell , 2008 .

[5]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[6]  B. Maisch,et al.  Diagnosis and treatment of myocarditis: The role of endomyocardial biopsy , 2007, Current treatment options in cardiovascular medicine.

[7]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[8]  M. Zembala,et al.  Adjunctive therapy with low-molecular-weight heparin in patients with chronic heart failure secondary to dilated cardiomyopathy: one-year follow-up results of the randomized trial. , 2006, American heart journal.

[9]  Jared W. Magnani,et al.  Myocarditis: Current Trends in Diagnosis and Treatment , 2006, Circulation.

[10]  K. Baughman Diagnosis of myocarditis: death of Dallas criteria. , 2006, Circulation.

[11]  M. Kurrer,et al.  [Diagnosis and course of myocarditis: a survey in the medical clinics of Zurich University Hospital 1980 to 1998]. , 2000, Schweizerische medizinische Wochenschrift.

[12]  R. Hruban,et al.  Echocardiographic findings in fulminant and acute myocarditis. , 2000, Journal of the American College of Cardiology.

[13]  K. Leslie,et al.  Evaluation of the effects of low molecular weight heparin on inflammation and collagen deposition in chronic coxsackievirus B3-induced myocarditis in A/J mice. , 1992, The American journal of pathology.

[14]  G. Hutchins,et al.  Clinicopathoiogic description of myocarditis , 1991 .

[15]  G. Hutchins,et al.  Clinicopathologic description of myocarditis. , 1991, Journal of the American College of Cardiology.

[16]  J. Mason,et al.  Diagnosing and treating active myocarditis. , 1989, The Western journal of medicine.

[17]  J. McPherson,et al.  The influence of heparin on the wound healing response to collagen implants in vivo. , 1988, Collagen and related research.